Literature DB >> 11334852

Evidence for a K(ATP) ion channel link in the inhibition of hypercapnic dilation of pial arterioles by 7-nitroindazole and tetrodotoxin.

W I Rosenblum1, H A Kontos, E P Wei.   

Abstract

7-Nitroindazole, an inhibitor of neuronal nitric oxide synthase, reportedly inhibits hypercapnic dilation, but tetrodotoxin, an inhibitor of neuronal transmission, reportedly does not. Thus, evidence does not uniformly support the hypothesis of a neurogenic link to the hypercapnic response. Others suggest the hypercapnic response is mediated by a K(ATP) ion channel. In the following studies, we observed that topically administered tetrodotoxin inhibited dilations produced by hypercapnia. In addition, topical tetrodotoxin and either topical or intraperitoneal 7-nitroindazole, inhibited dilations produced by the K(ATP) channel openers, cromakalim and pinacidil. Inhibition of hypercapnic dilation and inhibition of dilation by the openers of the K(ATP) channel was immediately reversed by either L-lysine or L-arginine, amino acids previously shown to facilitate opening of the channel. The data strongly supports the previous conclusion that there is a K(ATP) ion channel link in the response of pial arterioles to hypercapnia. The location of the channel is not established by these data, nor is it known whether the action of tetrodotoxin on the channel was direct or indirect.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11334852     DOI: 10.1016/s0014-2999(01)00899-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Does hypercapnia-induced impairment of cerebral autoregulation affect neurovascular coupling? A functional TCD study.

Authors:  Paola Maggio; Angela S M Salinet; Ronney B Panerai; Thompson G Robinson
Journal:  J Appl Physiol (1985)       Date:  2013-06-06

Review 2.  Acid-base regulation and sensing: Accelerators and brakes in metabolic regulation of cerebrovascular tone.

Authors:  Ebbe Boedtkjer
Journal:  J Cereb Blood Flow Metab       Date:  2017-10-06       Impact factor: 6.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.